XML 65 R63.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity - Schedule of Stock Option Activity (Detail)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Number of Shares, Outstanding at December 31, 2019 | shares 436
Number of Shares, Exercised | shares (17)
Number of Shares, Forfeited | shares (33)
Number of Shares, Outstanding at March 31, 2020 | shares 386
Number of Shares, Exercisable at March 31, 2020 | shares 378
Number of Shares, Vested and expected to vest at March 31,2020 | shares 386
Weighted - Average Exercise Price Per Share, Outstanding, Beginning balance | $ / shares $ 35.62
Weighted - Average Exercise Price Per Share, Exercised | $ / shares 33.53
Weighted - Average Exercise Price Per Share, Forfeited | $ / shares 38.46
Weighted - Average Exercise Price Per Share, Outstanding, Ending balance | $ / shares 35.47
Weighted - Average Exercise Price Per Share, Exercisable at March 31, 2020 | $ / shares 35.42
Weighted - Average Exercise Price Per Share, Vested and expected to vest at March 31,2020 | $ / shares $ 35.47
Weighted - Average Remaining Contractual Term, Outstanding at March 31, 2020 3 years 6 months 14 days
Weighted - Average Remaining Contractual Term, Exercisable at March 31, 2020 3 years 6 months 21 days
Weighted - Average Remaining Contractual Term, Vested and expected to vest at March 31, 2020 3 years 6 months 14 days
Aggregate Intrinsic Value, Outstanding at March 31, 2020 | $ $ 4
Aggregate Intrinsic Value, Exercisable at March 31, 2020 | $ 4
Aggregate Intrinsic Value, Vested and expected to vest at March 31, 2020 | $ $ 4